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Abstract
The neurotrophic tyrosine kinase receptor type 2 (Ntrk2, also known as TrkB) and its
ligands brain derived neurotrophic factor (Bdnf), neurotrophin-4 (NT-4/5), and neurotrophin-
3 (NT-3) are known primarily for their multiple effects on neuronal differentiation and surviv-
al. Here, we provide evidence that Ntrk2 plays a role in the pathologic remodeling of the
spleen that accompanies chronic infection. We show that in Leishmania donovani-infected
mice, Ntrk2 is aberrantly expressed on splenic endothelial cells and that new maturing
blood vessels within the white pulp are intimately associated with F4/80hiCD11bloCD11c+
macrophages that express Bdnf and NT-4/5 and have pro-angiogenic potential in vitro. Fur-
thermore, administration of the small molecule Ntrk2 antagonist ANA-12 to infected mice
significantly inhibited white pulp neovascularization but had no effect on red pulp vascular
remodeling. We believe this to be the first evidence of the Ntrk2/neurotrophin pathway driv-
ing pathogen-induced vascular remodeling in lymphoid tissue. These studies highlight the
therapeutic potential of modulating this pathway to inhibit pathological angiogenesis.
Author Summary
Visceral leishmaniasis (VL), a globally important parasitic disease responsible for over
40,000 deaths p.a., results in pronounced changes in splenic organisation associated with im-
paired immune function and persistent parasite infection. We have previously shown that
receptor tyrosine kinase (RTKi) inhibitors can restore splenic architecture and improve im-
munocompetence, and that mononuclear phagocytes (MPs) are involved in this process.
Here, we provide evidence that neurotrophin receptor Ntrk2 (also known as TrkB) plays a
role in the pathologic remodeling of the spleen that accompanies experimental Leishmania
donovani-infection. We show that following infection of mice with L.donovani, Ntrk2 is ex-
pressed on splenic endothelial cells that are closely associated with F4/80hiCD11bloCD11c+
macrophages expressing Ntrk2 ligands. Administration of the Ntrk2 antagonist ANA-12
to infected mice significantly inhibited compartment-specific vascular remodeling of the
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spleen. This study expands our understanding of the pathogenesis of experimental VL and
also demonstrates the potential of Ntrk2/Bdnf as targets for treatment of infection-induced
vascular remodeling.
Introduction
Disruption in lymphoid tissue organisation is evident in a wide array of chronic inflammatory
disorders, including cancer, infectious disease, psoriasis, liver disorders, autoimmune and met-
abolic diseases, and the persistence of vascular remodelling has been shown to impair immune
responses and promote the chronicity of inflammation [1–4]. It is perhaps no surprise, there-
fore, that anti-angiogenic drugs are becoming an important therapeutic option for an array of
chronic diseases and disorders, including those of infectious origin. HIV, malaria, schistosomi-
asis and leishmaniasis all promote chronic inflammation and remodelling of lymphoid organs
[5–8], and murine models of these diseases have been used extensively to study the mechanistic
basis of stromal cell and vascular remodelling and their consequences in terms of immune dys-
function and disease progression [7,9–11].
Splenomegaly is a defining characteristic of the parasitic disease visceral leishmaniasis (VL)
and like many examples of splenomegaly, VL is associated with a remodeling of splenic archi-
tecture [4,12]. In murine experimental VL, enlargement of red pulp vessels and neovasculariza-
tion of the white pulp are prominent. Previously, we demonstrated that administration of the
broad spectrum receptor tyrosine kinase inhibitor (RTKi) sunitinib maleate to Leishmania
donovani-infected mice halted progressive vascular remodeling, reduced mononuclear phago-
cyte (MP) number and improved the efficacy of immune-dependent drugs [4,13,14]. Compart-
ment-specific remodeling of the red pulp vasculature was subsequently identified as a function
of Ly6C+ inflammatory monocytes [14], whereas these cells played no apparent role in regulat-
ing white pulp neovascularisation or the loss of follicular dendritic cells (FDC) and fibroblastic
reticular cells (FRC), suggesting alternate and independent mechanisms exist to regulate
these processes.
Neurotrophins and their receptors are novel targets for angiogenic therapies [15,16]. For ex-
ample, Bdnf is recognised as an angiogenic factor, being critical for the establishment of cardiac
vasculature during development [17,18], and for promoting Ntrk2-dependent skeletal muscle
neoangiogenesis in adult ischemic hind limbs [19]. However, it is the limited tissue expression
of the neutrophin receptors, such as Ntrk2, which makes them so desirable as targets for thera-
py, with the potential for aberrant expression in pathological conditions in other tissues being
largely overlooked.
MPs are recognized as playing a significant role in inflammation-induced angiogenesis
[2,20] and MP are known to be a source of Bdnf and NT-4/5 with their production being in-
creased upon inflammatory stimulation [21,22]. Chronic parasitic and bacterial infections have
also been associated with elevated levels of Bdnf/BDNF [23–25]. For example, serum levels of
BDNF were significantly higher in patients suffering from chronic Chagas disease compared to
healthy controls [25]. However, the cellular source(s) of neurotrophin were not determined in
these studies. A causal link, therefore, between neurotrophin expression and infection-induced,
macrophage-directed angiogenesis has not been previously reported.
Here, we report that Ntrk2 is aberrantly expressed on endothelial cells that form newly
emerging vessels within the white pulp during L. donovani infection and that expression of
Bdnf is up regulated in a sub-population of MPs with phenotypic similarity to resident tissue
macrophages. Together, these observations have important implications for understanding the
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pathogenesis of VL and illustrate the potential for aberrant expression of angiogenic receptors
and their ligands during inflammation.
Results
Characterisation of MPs in Leishmania infected mice
To determine whether MPs were involved in the process of white pulp remodeling, we first
characterized MPs in the spleen of sunitinib-treated and control mice after the onset of spleno-
megaly (d28 post infection;[4]). Three distinct populations of CD11c+MHCII+ MPs were iden-
tified in infected mice based on CD11b, F4/80 and forward/side scatter profile and
morphology: F4/80hiCD11blo cells (large, macrophage-like morphology;*80% containing
parasites; Fig. 1A); F4/80loCD11bhi cells (smaller, classic macrophage morphology,<5% in-
fected; Fig. 1B); and F4/80loCD11blo cells (small, dendritic cell morphology, no parasites;
Fig. 1C). These MP populations increased in number 9–14 fold in infected compared to naïve
Fig 1. Sensitivity of mononuclear phagocytes in L.donovani infectedmice to RTKi treatment.CD11c+MHCII+MPs in d28 L. donovani infected mice
were distinguished on the basis of F4/80 and CD11b expression, forward/side scatter profile and morphology into: (A) large CD11c+MHCII+F4/80hiCD11blo
(F4/80hiCD11blo) cells with macrophage-like morphology, of which*80% harbored intracellular parasites; (B) slightly smaller CD11c+MHCII+F4/
80loCD11bhi (F4/80loCD11bhi) cells with classic macrophage morphology, of which<5% harbored parasites; (C) much smaller CD11c+MHCII+F4/
80loCD11blo (F4/80loCD11blo) cells with dendritic cell-like morphology and no observable parasites. Representative dot plots show pre-sorted populations
with ellipsoid sort gates based on F4/80 and CD11b expression. Scale bar in micrographs = 10microns. The frequency and absolute numbers of each
population is given in the right hand panels in naïve mice, infected mice and infected mice treated orally with sunitinib (Sm) for 7 days. P values = *<0.05,
**<0.008, ***<0.001, ns = not significant.
doi:10.1371/journal.ppat.1004681.g001
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mice. Although administration of sunitinib reduced the number of all populations, this was
most marked for the F4/80hiCD11blo cells (Fig. 1A-C, right panels).
As the sensitivity of F4/80hiCD11blo MPs to sunitinib treatment correlated with inhibition
of white pulp neovascularisation, we further characterized these cells in both untreated infected
and sunitinib-treated infected mice. Phenotypically, F4/80hiCD11blo MPs from both groups of
mice were CD68+Ly6G/C- CD80+ SIGNR1loCD115+/- (Fig. 2A-C), suggesting that these MPs
might be resident rather than inflammatory monocytes / macrophages. To further characterize
these cells, we used an in-house MP-targeted oligoarray (consisting of>500 genes representing
multiple GO pathways; S1 Table) to identify genes differentially expressed (DE) in F4/
80hiCD11blo MPs vs. a reference population of F4/80hiCD11blo peritoneal MPs. The top DE
gene was Slc40a1, an iron export protein expressed at high levels by tissue resident red pulp
macrophages (Table 1), with many other DE genes being associated with pro-inflammatory
and IFNγ-regulated responses, e.g. Cxcl9, Il18, Fpr2 and Ccl4 (Table 2 and S2 Table).
F4/80hi CD11bloMPs are associated with blood endothelial cells in the
splenic white pulp
F4/80himacrophages were described 30 years ago immediately adjacent to arterioles in the
periarteriolar lymphoid sheath [26,27]. We localized F4/80hiCD11blo MPs in situ, taking ad-
vantage of their expression of SIGNR1, a receptor for the uptake of FITC-dextran [28], and the
absence of SIGNR1himarginal zone macrophages in L. donovani infected mice [11]. 74% of
cells labeled intra-vitally with FITC-dextran were CD11c+F4/80hiCD11blo (gating strategy in
S1 Fig.). In situ, F4/80hiCD11blo FITC-dextran+ MPs were located in either the white pulp re-
gion of the spleen or adjacent to the MZ (Fig. 3A, B). F4/80hiCD11blo MPs were most com-
monly (87.5%±7.2) found in association with Meca32+ vessels adjacent to the MZ or no more
than a distance of two cell nuclei away (8.3% ± 8), and located predominantly at vessel junc-
tions (Fig. 3C, D). x-y-z- reconstructions confirmed that they were closely associated with
Fig 2. Phenotypic analysis of F4/80hiCD11blocells. Splenocytes isolated from L.donovani infected mice at 28 days post infection were stained with a panel
of myeloid cell markers. CD11c+MHCII+F4/80hiCD11bloMPs were positive for CD80, CD68 and a small proportion (15%) expressed CD115 (A: isotype
control, filled grey histogram). Strong SIGNR1 (white) and FITC-dextran (green) labeling co-localise in the marginal zone of naïve mice (B), whereas in
infected mice FITC-dextran+ (green) cells had low expression of SIGNR1 (white). FITC-dextran+ (green) cells were negative for GR1 (white) in both naïve
and infected mice (C). Scale bars = 100 microns.
doi:10.1371/journal.ppat.1004681.g002
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smooth muscle actin (SMA)-positive cells (S1 Video). Finally, 3D-rendering of z-plane images
confirmed the presence of F4/80hiCD11blo MPs tightly associated with vessel junctions
and vasculature that protruded into the white pulp from the marginal sinus (Fig. 3E-F and
S2 Video).
F4/80hi CD11bloMPs are pro-angiogenic
The close association of F4/80hiCD11blo MPs with vessels penetrating the white pulp suggested
that there maybe a causal relationship with vascular remodeling. To determine the angiogenic
potential of F4/80hiCD11blo MPs, we used SVEC4–10 mouse endothelial cells in an in vitro
Table 1. Altered gene expression in F4/80hiCD11blo cells compared to control macrophages.
Gene Fold change Gene Fold change
Slc40a1 6.44 Ticam1 -11.36
Cxcl9 3.77 Tgfb2 -3.28
Il18 3.42 Spi1 -3.13
Tgfb3 3.13 Il1r1 -2.72
Fpr2 2.85 Il1rn -2.60
Ccl4 2.74 Xcl1 -2.57
Arhgdia 2.72 Ccr1 -2.38
Il1b 2.72 Sp1 -2.31
Mr1 2.71 Arg1 -2.29
Clec4n 2.69 Hif1an -2.23
doi:10.1371/journal.ppat.1004681.t001
Table 2. Comparison of growth factor mRNA abundance in F4/80hiCD11blo cells compared to other
MP populations isolated from L. donovani-infected spleens.
Gene Fold change relative to:
F4/80lo CD11bhi CD11blo F4/80lo CD11cneg
Bmp4 44.32 6.68 17.88
Bdnf 21.26 2.36 2.38
Cxcl12 18.01 6.20 10.70
Bmp2 15.35 8.22 5.82
Bmp6 13.10 2.81 4.50
Tgfa 12.47 5.47 4.82
Fgf11 9.85 18.51 15.24
Kitl 8.22 15.67 4.47
Tdgf1 6.92 3.51 3.41
Ntf5 6.32 4.06 4.06
Fgf1 6.19 4.32 4.20
Igf1 5.82 15.67 5.62
Pdgfa 5.35 5.35 4.89
Il18 3.43 16.56 4.38
Tgfb3 -3.92 -15.89 -10.56
Artn -2.75 -3.43 -10.34
Pgf -2.10 -4.29 -5.78
Csf1 -2.04 -2.91 -4.14
doi:10.1371/journal.ppat.1004681.t002
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Fig 3. F4/80hiCD11bloMPs are located in close proximity to white pulp vasculature and possess
angiogenic properties. F4/80hiCD11blo cells (FITC-dextran, green; yellow arrows) identified in fresh frozen
Endothelial Neutrotropic Receptor Expression in Leishmaniasis
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tube formation assay. SVEC4–10 cells cultured in the presence of an optimized cocktail of
growth factors (EGM) migrated, directionally align and formed tube networks to a greater ex-
tent than cells cultured in in basal media (EBM) (Fig. 3G). Addition of F4/80loCD11bhi and F4/
80loCD11blo cells had negligible tube promoting activity (<20% of maximal activity; difference
in tube length of 2.2±2.3% and 2.1±2.7%, respectively vs. EBM control), whereas F4/80hiCD11blo
MPs significantly enhanced mean loop area and tube length (5.7±3.0% and 8.6±3.1% for F4/80hi
CD11bloMPs and EGM respectively, compared to EBM control; Fig. 3G-I). Hence, of the splenic
MPs tested, only F4/80hiCD11bloMPs displayed angiogenic activity in vitro.
To identify factors associated with the angiogenic activity of these MPs, we studied the
expression of 84 angiogenesis-related genes using PCR array. 69% (58/84) of genes were DE (2-
fold cut-off) in F4/80hiCD11blo MPs relative to F4/80loCD11bhi MPs (46 up, 12 down), 50%
(42/84) were DE relative to F4/80loCD11blo MPs (28 up, 14 down) and 55% (46/84) were DE
relative to non-adherent CD11c- splenocytes (28 up, 18 down). 21% (18/84; 14 up, 4 down)
were DE relative to all groups (Table 2). These included several members of the Tgf family
and known ligands for sunitinib, including Pdgf, Kitl Artn, Pgf and Csf1. Neurotrophic factors
Fgf11, Bdnf andNtf5 (neurotrophin 4/5) were all up regulated in F4/80hiCD11bloMPs (Table 1).
F4/80hiCD11bloMPs also expressed higher levels of Bdnf protein compared to other MP popu-
lations studied (ΔMFI = 811 vs ΔMFI = 247 and ΔMFI = 139; Fig. 4A). Although we cannot rule
out a causal link between intracellular infection of F4/80hiCD11bloMPs by L. donovani amasti-
gotes and their Bdnf expression, Bdnf gene expression was not enhanced following L. donovani
infection of a variety of other MPs in vitro [29] and in vivo [30]. In summary, these data demon-
strate that F4/80hiCD11bloMPs in infected mice: i) are appropriately positioned in the tissue; ii)
express neurotrophins with known angiogenic activity; and iii) are pro-angiogenic in vitro.
Nrtk2 expression on vasculature following infection in vivo
Spleen tissue sections were analyzed for the expression of Ntrk2, the receptor for Bdnf to inves-
tigate a possible role for this pathway in vascular remodeling in vivo. In the naïve spleen, Ntrk2
expression was restricted to a population of F4/80+ red pulp MPs, corresponding to previous
reports [31] (Fig. 4B). Expression of Ntrk2 was not altered at d1 post infection, suggesting that
induction of Ntrk2 was not the result of inflammatory responses that immediately follow infec-
tion. Induced expression was seen in the marginal zone area at day 7 post infection and staining
within the white pulp area was beginning to become apparent at day 14 (S2 Fig.). In spleens
from chronically infected mice, Nrtk2 was aberrantly expressed on stromal cells, with white
pulp vessels showing the highest intensity of staining for Ntrk2 (Fig. 4C). Ntrk2+ vessels were
found to be in extremely close association with CD11c+F4/80+ MPs (Fig. 4C). Ntrk2 expression
has been reported on endothelial cells and smooth muscle cells in developing and adult cardiac
sections as located either in or bordering the white pulp (A,B). Red pulp F4/80+macrophages are also shown
(white). F4/80hiCD11blo cells (FITC-dextran, green) were found in close association with endothelial cells (C,
E; Meca-32, magenta) but not follicular dendritic cells (D; FDCM1, red). High magnification image of area
depicted by yellow circle in e (F). All sections were counterstained with DAPI (blue). Scale bars = 100
microns. F4/80hiCD11blo cells, but not other splenic MPs tested, drive SVEC4–10 endothelial cell tube
formation on a gelled basement membrane extract (G). Representative images are shown. An optimised
cocktail of growth factors (EGM) was used as a positive control. Quantitative analysis of SVEC4–10 mean
loop area (H) and difference in tube length (I), in the presence of each MP population or control growth
factors. Mean loop area in the absence of growth factors or MPs is shown as a dotted line in h. *p = 0.05,
**p = 0.02. Images were analysed usingWimTube software and data are expressed as mean ± SEM from at
least three independent experiments.
doi:10.1371/journal.ppat.1004681.g003
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tissue [18,32]. Co-staining with Meca32 indicated that Ntrk2 was expressed on splenic endo-
thelial cells, but vessels associated with high levels of SMA staining did not express detectable
levels of Ntrk2 (Fig. 4D). As SMA acquisition is a marker of vessel maturity [33], these data
suggest that Ntrk2 is up regulated only on developing or immature blood vessels.
Fig 4. Infection-induced expression of Bdnf and Ntrk2 in spleen. Bdnf (black line) was expressed at significantly higher levels by F4/80hiCD11blo cells
compared to the other MP populations tested, as revealed by delta median fluorescence intensity levels (ΔMFI) using intracellular flow cytometry (A). Isotype
control staining is highlighted by the solid grey histogram. Ntrk2 (red) expression in naïve mouse spleen is found in a subset of splenic red pulp macrophages
(F4/80+, white) in naïve mouse spleen (B). Scale bar = 200microns. In L. donovani infected mice splenic white pulp vessels expressed Ntrk2 (C: red). F4/80+
(white) CD11c+ (green) MPs are found in close association with Nrtk2+ vessels (C: merge and inset). Endothelial cells (Meca-32, green) but not smooth
muscle actin-positive cells (SMA, red) in white pulp express Nrtk2 (white, D and inset). All sections were stained with DAPI (blue). Scale bars = 100 microns
and 50 microns in high magnification merge image.
doi:10.1371/journal.ppat.1004681.g004
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Pharmacologic blockade of Ntrk2 inhibits neovascularisation
Finally, to determine whether this pathway played a functional role in vascular remodeling, we
inhibited Ntrk2 signaling in vivo using the small molecule antagonist ANA-12 [34]. Mice were
treated for 7 days i.p. with sunitinib or ANA-12 commencing on day 21 p.i. [4] (Fig. 5A).
Quantitative image analysis indicated that sunitinib [4] but not ANA-12 inhibited red pulp
vascular remodeling (Fig. 5B and C). In contrast, both sunitinib and ANA-12 significantly in-
hibited white pulp neovascularization (50%±10 and 34%±8 reduction vs. vehicle control, re-
spectively; Fig. 4B and D). ANA-12 did not alter splenic parasite burden, as was also the case
for sunitinib (Fig. 5E). Unlike sunitinib, however, ANA-12 treatment had no significant effect
on spleen size (Fig. 5F) suggesting that splenomegaly and red pulp vascular remodeling are
linked. Similarly, MP frequency was unaltered following ANA-12 treatment (1.15±0.1% vs
1.0±0.1% for F4/80hiCD11blo MPs, 5.83±0.5% vs 5.82±0.3% for F4/80loCD11bhi MPs and
5.25±0.5% vs 5.3±1.5% for F4/80loCD11blo MPs, comparing ANA-12 to vehicle). Collectively,
these data demonstrate that targeting Ntrk2 signaling in vivo selectively inhibits ongoing white
pulp neovascularization, without affecting MP infiltration and/or proliferation or splenomega-
ly and red pulp vascular remodeling (Fig. 6).
Fig 5. White pulp neovascularization during chronic infection is dependent on Nrtk2.Drug treatment schedule: 21 days post infection with L. donovani,
mice were treated with ANA-12, sunitinib maleate (Sm) or vehicle control (VC), daily for 7 days (A). Spleen sections from control and drug-treated mice were
stained for endothelial cells (Meca-32, red) and F4/80 (green) to identify boundary of the red and white pulp (white lines). Representative whole slide scanned
images are shown (B). The proportion of red pulp area (C) occupied by endothelial cells (Meca-32) and expression of Meca32 relative to total white pulp area
(D) was determined by computer-assisted morphometry. Data are expressed as mean ± SEM of at least two independent experiments where n = 5 for each
treatment. ** p<0.02 *p<0.05. Spleens were examined after drug treatment for parasite burdens (E) and size/body weight ratio (F).
doi:10.1371/journal.ppat.1004681.g005
Endothelial Neutrotropic Receptor Expression in Leishmaniasis
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Discussion
Chronic inflammation results from sustained immune mediated inflammatory responses lead-
ing to significant tissue destruction and / or remodeling, but the cells and mechanisms involved
in these processes, especially in the context of infectious disease, are not fully understood. Our
data provides the first evidence that the neurotrophic receptor Ntrk2 and its ligands play a role
in mediating pathological vascular remodeling. First, we show that Ntrk2 is aberrantly express-
ed on lymphoid tissue (white pulp) vasculature in the spleen of mice with chronic infection-as-
sociated inflammation. This contrasts with the largely CNS-restricted expression of Ntrk2
expression observed in healthy adult tissues. Second, we have identified a population of splenic
F4/80hi CD11blo MPs that express Ntrk2 ligands and possess all the characteristics needed to
drive white pulp vascular remodeling. Third, we demonstrate that a selective antagonist of
Ntrk2 inhibits ongoing white pulp neovascularization.
Angiogenesis and inflammation have long been thought of as co-dependent processes and
there is increasing evidence that disruption to vasculature prolongs and intensifies the inflam-
matory response [35]. It has been shown that MPs are recruited to sites of neoangiogenesis and
support neovascularization by releasing angiogenic factors, including VEGF, PDGF, FGF and
metalloproteinases [36–38]. Recently, evidence has suggested that neuronal factors such as
neurotrophic factors, ephrins, bone morphogenetic proteins (BMPs) and their receptors
[19,39,40], can also play critical roles as angiogenic regulators. A study by Kermani et al
highlighted that Bdnf promoted neovascularization in ischemic adult limbs and this correlated
with the expression of Ntrk2 on endothelial cells. In agreement with that study, we found en-
richment of Bdnf in F4/80hi CD11blo MPs and could directly show that these cells were closely
associated with endothelial cells expressing Ntrk2. The expression of Ntrk2 by splenic endothe-
lial cells was only observed in chronic infection and was not evident in the steady-state.
ANA-12 is a low molecular weight heterocyclic compound that was identified using a novel
structure-based in silico screening technique as a selective Ntrk2 inhibitor [34]. In mice, ANA-
12 has been shown to have anti-depressant and anti-anxiolytic activity [34] and it alters co-
caine-mediated behaviour in rats [41]. Ntrk2 is also targeted, less selectively by other RTKi’s in
the clinic or in early stage clinical development e.g. Lestaurtinib (for neuroblastoma;[42]) and
PLX7486 (pancreatic adenocarcinoma; ClinicalTrials.gov identifier: NCT01804530). If aber-
rant expression of Ntrk2 is confirmed in other settings of chronic inflammation associated
with pathogenic angiogenesis, Ntrk2-selective drugs may provide a new therapeutic option for
treatment of these conditions. Importantly, the potential for aberrant expression and function
of this neurotrophic receptor, as shown here, also highlights the need to consider inflammation
when designing organ-specific therapeutics.
Fig 6. Schematic diagram of the effects of treatment with RTK inhibitors during L.donovani infection.Cartoon to depict processes inhibited by the
broad spectrum RTKi (Sm) and the selective Nrtk2 inhibitor (ANA-12) during infection-associated neovascularization of white pulp.
doi:10.1371/journal.ppat.1004681.g006
Endothelial Neutrotropic Receptor Expression in Leishmaniasis
PLOS Pathogens | DOI:10.1371/journal.ppat.1004681 February 24, 2015 10 / 17
Developmentally, tissue macrophages are known to have functions in matrix remodeling
[43], epithelial proliferation and outgrowth [44], angiogenesis and tissue organization
[45,46]. It has been suggested that in chronic disease, the developmental activities of macro-
phages are dysregulated and that these activities contribute to disease pathology [47]. This is
evident in some models of cancer where depletion of macrophages or inhibition of macro-
phage access to the tumor site inhibits tumor growth and angiogenesis[48–51]. Gene expres-
sion signatures of tumour-associated macrophages revealed enrichment in genes associated
with developmental functions including matrix remodeling, and angiogenesis [52]. Consis-
tent with these findings, F4/80hi CD11blo MPs isolated from the spleen of L. donovani-in-
fected mice revealed enrichment in expression of genes functionally related to cancer and
cell survival. These cells displayed angiogenic properties in vitro and given their spatial rela-
tionship with emerging blood vessels, it is highly likely that these cells are playing a role in
neovascularisation in vivo.
Splenic macrophages are themselves a heterogeneous population, of which the immuno-
logical phenotype and immunological function of all populations has still not been exten-
sively explored, particularly during chronic inflammation. The CD11c+MHCII+F4/80hi
CD11blo MP population identified here that is expanded during L. donovani infection is rare
in the spleen of uninfected mice, making it hard to draw direct comparisons with any func-
tion of these cells in the steady-state. F4/80+ macrophages found in the white pulp of the
spleen were originally described 30 years ago in adult mice to be immediately adjacent to ar-
terioles in the periarteriolar lymphoid sheath [26], and later studies defined these MPs as
having high expression of the F4/80 antigen [27]. Although the low expression of SIGNR1
suggests that these MPs may have some relationship to marginal zone macrophages, cell-
tracking studies of MZM in the spleens of infected mice suggest that most bone fide MZM
are lost from the spleen during infection [11]. A formal identification of the relationship of
the CD11c+MHCII+F4/80hi CD11blo MP population described here to different splenic MP
populations present in the steady state would require lineage tracking studies that are be-
yond the scope of the current manuscript.
Finally, the impact of ANA-12 on tissue remodeling was highly selective compared to the
impact we have previously observed using a broader spectrum RTKi, sunitinib maleate. Follow-
ing sunitinib administration, the ongoing remodeling of red and white pulp vasculature is
halted and follicular dendritic cell and fibroblastic reticular cell networks are largely restored
[4]. In contrast, the impact of ANA-12 administration was selective for white pulp neovascular-
ization. Likewise, whereas red pulp vasculature is remodeled largely by Ly6C+ inflammatory
monocytes, white pulp neovascularization appears to reflect the more local behavior of MPs
with a more resident-like phenotype. Further studies will be required to determine whether se-
lective blockade of white pulp neovascularization using ANA-12 has any selective effects on
immune function than might support its use in combination therapy for disease such as leish-
maniasis, where lymphoid tissue remodeling is so prominent. However, in common with
broader spectrum RTKi, placental expression of Ntrk2 and the influence of maternal energetic
status on placental Ntrk2 expression[53] would likely be an impediment to development of
this and similar drugs for the treatment of women of childbearing age.
In conclusion, we have shown that selected features of pathogenic angiogenesis induced
by chronic infection are mediated through the interaction of a neurotrophic receptor with
ligands produced by local MPs. Our data provide new insights into the role of the neurotro-
phins and their receptors in inflammation, and further characterize the exquisite compart-
ment specific nature of tissue remodeling processes. The role of macrophage expression of
Bdnf in other chronic infectious and inflammatory disease settings clearly warrants further
study.
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Materials and Methods
Ethics statement
All animal care and experimental procedures were regulated under the Animals (Scientific Pro-
cedures) Act 1986 (revised under European Directive 2010/63/EU) and were performed under
UK Home Office License (Ref # PPL 60/4377) and with approval from the Animal Procedures
and Ethics Committee of the Department of Biology, University of York.
Experimental infection and treatment
Female C57BL6 CD45.1 and CD45.2 mice were obtained from Charles River UK, housed
under specific pathogen-free conditions and used at 6–10 weeks of age. The Ethiopian strain of
L. donovani (LV9) was maintained by passage in RAG-2-/- mice. Mice were infected by inject-
ing 3x107 amastigotes i.v. via the lateral tail vein (total n = 20 for each treatment experiment).
Animals were then allocated to treatment groups. Sunitinib maleate (35mg/kg; Sequoia Re-
search Products Ltd) (n = 5) or ANA-12 (1mg/kg; Sigma) (n = 5) was administered daily via
oral gavage or intraperitoneally for 7d. Vehicle-treated mice received citrate-buffered saline,
pH 3.5 (Sm) or PBS/1% DMSO (ANA-12) (n = 5). A sample size of 5 for each experiment was
required to detect a 30% change in vascularization at 80% power based on previous data [4].
For FITC-dextran uptake, 70,000 MW FITC-dextran was injected i.v. at 10mg/ml one hour be-
fore animals were sacrificed.
Cell culture of SVEC4–10 cells
Murine endothelial cells (ATCC) were grown in DMEMmedia supplemented with 10% heat
inactivated FCS in an atmosphere of 95% air and 5% CO2 at 37°C in plastic flasks. At conflu-
ence, the cells were subcultured at a 1:3 ratio and used at passage numbers three through to
ten. Cells were tested for mycoplasma contamination using MycolAlert mycoplasma detection
kit (Lonza, Cat No: LT07–418)
Microarray and pathway analysis
Custom microarrays with 568 gene probes, including 32 control probes were printed in-house.
The 536 test probes were chosen to provide insight into the various functions and signalling
pathways of macrophages.
Total RNA was isolated from splenic macrophages from L.donovani-infected mice (experi-
mental samples) and from naive pooled peritoneal macrophages (reference sample). Amplified
reference and experimental RNA fluorescently labelled with Cy3 or Cy5 were combined in
equal amounts on custom printed microarray slides and hybridised overnight at 42°C. The av-
erage experimental: reference ratios were compared by t-tests. Microarray data was analysed
using Ingenuity Pathways Analysis. The web-based pathways analysis tool IPA (Ingenuity Sys-
tems, www.ingenuity.com) was used to identify biological and molecular networks. Knowledge
coming from published, peer-reviewed scientific publications is stored in the Ingenuity Path-
ways Knowledge Base (IPKB) and is continuously updated, this web-based tool then allows for
the mapping of gene expression data into relevant pathways based on their functional annota-
tion and known molecular interactions. The genes considered to have been differentially regu-
lated to a significant extent when comparing F4/80hiCD11blo cells with conventional
peritoneal macrophages were uploaded into IPA along with the gene identifiers and corre-
sponding fold change values. In the network analysis, networks of these genes are then algorith-
mically generated based on their connectivity. The functional analysis of a network identified
the biological functions and/or diseases that were most significant to the genes in the network,
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and the functional analysis of the entire data set identified the biological functions and/or dis-
eases that were most significant to the data set.
Flow cytometry and cell sorting
Mononuclear cells were prepared from the spleens of C57BL6 L. donovani infected mice. Iso-
lated cells were labelled with F4/80 (clone: BM8), CD11c (clone: N418), CD80 (clone: 16–
10A1), CD86 (clone: GL1), CD40 (clone: IC10), CD115 (clone: AFS98), MHCII (clone: M5/
114), CD11b (clone: M1/70), Gr-1 (Ly6C/G clone: RB6–8C5) all purchased from eBioscience
and CD68 (clone FA-11) and CD169 (clone MOMA-1) were purchased from Serotec. Intracel-
lular cytokine staining was performed following surface staining on fixed cell (2% paraformal-
dehyde) and then permeabilised with 0.5% saponin. Cells were analyzed using a cyAn flow
cytometer and analyzed using Summit software (Beckman Coulter). Cells were sorted based on
forward and side scatter and expression of PE or PE-Cy7 conjugated anti-CD11c, Alexa Fluor
450 anti-MHCII, Alexa Fluor 488 conjugated anti-CD11b and Alexa Fluor 647 anti-F480 on a
MoFlo cell sorter (Beckman Coulter). Sorted cells were then used for tube formation assays,
analysed for mRNA expression or morphological analysis was carried out with approximately
3000 sorted cells spun onto glass slides, fixed in methanol and stained with Giemsa. Light mi-
croscopy was conducted on a Zeiss Axioplan and imaged with an Optronics CCD camera
using MagnaFire software (Optronics).
Confocal microscopy
Phenotypic analysis of MPs was also carried out on splenic frozen sections. Sections (6–10μm)
from FITC-dextran injected, infected or uninfected mice were acetone fixed and labeled with
biotin conjugated Gr-1 or biotin conjugated F4/80 and Alexa fluor 647 SIGNR1 (eBioscience).
Thicker sections (10–30μm) were used to assess the location of MPs within the spleen. Sec-
tions were labeled with a purified rat anti mouse pan endothelial cell antigen antibody (Biole-
gend, clone Meca-32) and/or a Cy3 labelled monoclonal antibody against α-Smooth Muscle
Actin (α-SMA) (Sigma, Clone 1A4) were used to identify endothelial cells or vessels. Rat anti-
mouse FDC antibody (FDCMI) (BD Pharmingen) was used to detect follicular dendritic cells.
Fluorochrome conjugated goat anti-rat antibody (Invitrogen) were used for detection of puri-
fied antibodies. Sections were counterstained with DAPI and mounted in Pro-long Gold anti-
fade (Invitrogen) and visualized using a Carl Zeiss upright LSMMETA 510, inverted LSM
META 710 confocal microscope or a Carl Zeiss Axio Scan.Z1 digital slide scanner with bright-
field and 4-colour fluorescence.
Tube formation assay
Angiogenesis assays were carried out as described previously [54]. Isolated splenocytes from
chronically infected mice were first enriched for MPs by plastic adherence for 1hr at 37oC in
RPMI (10% FCS) before cell sorting. Proliferating SVEC4–10 cells (1.5 x104 cells) were added
to sorted populations of MPs or non-adherent cells (2 x 104) in endothelial basal media-2, with
no FCS, (EBM-2; Lonza) and then plated onto growth factor-reduced Cultrex basement mem-
brane (BME; Trevigen) coated 96 well plates. Negative controls of SVEC4–10 cells in EBM-2
and positive controls of SVEC4–10 cells in endothelial cell growth media-2 (EGM-2; Lonza)
containing FCS and growth supplements (SingleQuot kit; Lonza) were included. Tube forma-
tion was assayed 4 hours after plating. Images were taken using a Zeiss inverted fluorescent mi-
croscope with x5 objective. All conditions were set up in each experiment in triplicate and
imaged. Images were then uploaded onto http://www.wimasis.com/ for independent blind
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analysis using WimTube, web-based image analysis software, which quantitatively evaluated
the generation of new vessels. Assays were analyzed by WimTube Quantitative Image Analysis.
Growth factor PCR array
Total RNA was extracted from the sorted cells using the RNeasy RNA isolation kit (Qiagen),
and then quantified using a Nanodrop ND-100. For the PCR array, 200ng of total RNA was re-
verse transcribed using RT2 First Stand Kit (Qiagen), and cDNA was directly added to PCR
Master mix containing SYBR green. The mixtures were then aliquoted into 96-well PCR array
plates, to profile the expression of 84 growth factor pathway-related genes using a mouse
growth factor signalling pathway RT2 Profiler PCR array (PAMM-041Z, Qiagen) according to
the manufacturer’s instructions. The array also included 6 housekeeping genes and 3 RNA as
internal controls. Arrays were run on an ABI 7300HT qPCR instrument equipped with SDS
2.3 software, using RT2 SYBR Green/ROX qPCR master mix (Qiagen). Data analysis was done
by the 2-ΔΔCt method on the manufacturer’s Web portal http://www.SABiosciences.com/
pcrarraydataanalysis.php
Statistics
Data are expressed values as means ± SEM. Comparison was performed using the unpaired
Student’s t-test (for data following a Gaussian distribution) and the Mann-Whitney test (for
data that did not assume Gaussian distribution). D’Agostino and Pearson omnibus normality
test was used to test for Gaussian distribution. A probability of less than 5% (P< 0.05) was
considered to be statistically significant. All statistical analyses were performed with Prism
v5.01 (GraphPad, Inc.) software.
Supporting Information
S1 Video. F4/80hiCD11blo cells are closely associated with splenic stroma. F4/80hiCD11blo
cells in day 28 infected mice were intravitally-labeled with FITC-dextran (green). 30-micron
spleen sections were stained with for smooth muscle actin (SMA) and Z stacks acquired in
1micron steps. 3D rendering was performed using VolocityTM software (Improvision). The
movie was exported at 10 frames per second (fps) and shows the SMA+ stromal network (red)
with tightly associated FITC-dextran+ cells. Nuclear staining was performed with DAPI (blue).
(MOV)
S2 Video. F4/80hiCD11blo cells are tightly associated with junctions of vasculature emanat-
ing from the white pulp border. F4/80hiCD11blo cells in day 28 infected mice were intravital-
ly-labeled with FITC-dextran (green). 30-micron spleen sections were stained with Meca32
(red) to highlight vasculature. FITC-dextran+ cells were found in very close association with
vessels, in particular with the branch point of vessels entering the white pulp. Z stacks were ac-
quired in 1micron steps and the 3D rendering done in VolocityTM software (Improvision).
The movie was exported at 10 frames per second (fps). Nuclear staining is shown in blue using
DAPI.
(MOV)
S1 Fig. F4/80hiCD11blo cells preferentially take up low molecular weight FITC-dextran in
L.donovani infected spleens.Mice at 28 days post infection with L.donovani were intravitally
labeled with 70kDa FITC-dextran 10mins before sacrifice. Flow cytometric analysis of spleno-
cytes positive for FITC staining confirmed that the majority of these cells were CD11c+
MHCII+ F4/80hi and CD11blo.
(TIF)
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S2 Fig. Kinetics of expression of Ntrk2 in the spleen of L. donovani infected mice.Mice
were infected with L. donovani and at time indicated, spleen sections were stained for Ntrk2.
A-D represent merged images (blue, DAPI; green, F4/80; red, Ntrk2, white, CD11c. E-H show
Ntrk2 with DAPI counterstaining only.
(TIFF)
S1 Table. Gene list for probes included on oligo-array.
(XLSX)
S2 Table. Top 300 probes by fold change in F4/80hiCD11blo cells compared to control mac-
rophages.
(XLSX)
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